In this episode of Causes or Cures, Dr. Eeks chats with Dr. Christoffer Clemmensen about his research on the psychedelic drug, psilocybin, and its connection to weight and energy balance. This podcast will mostly cover his animal study published here in Translational Psychiatry. As there is renewed interest in psychedelics and, of course, the ongoing obesity epidemic that is increasing around the globe, this is a doubly timely topic.
Specifically, he will discuss psilocybin, how it works in the body, its relation to "cognitive flexibility", and how it might be used for obesity. He will explain the results of his animal study involving psilocybin, the dosing riddle, and why he feels it should next be studied in humans.
Dr. Clemmensen heads the Clemmensen Group studies at the Novo Nordisk Foundation Center for Basic Metabolic Research. His research focuses on the biological regulation of body weight and aims to develop new therapeutic approaches for obesity and its metabolic consequences. You can learn more about him and his lab here.
You can contact Dr. Eeks at bloomingwellness.com.
Follow Dr. Eeks on Instagram here.
Or Facebook here.
Or Twitter.
Subscribe to her newsletter here!